Ryan Specialty Group (RYAN) AI Stock Analysis

• Market Cap: $14.52B
• Dividend Yield: 0.84%
• Average Volume (3M): 1.92M
• Price to Earnings (P/E): 431.9
• Beta (1Y): 0.26
• Revenue Growth: 22.77%
• EPS Growth: -34.97%
• Country: US
• Employees: 5,556
• Sector: Financial
• Sector Strength: 70
• Industry: Insurance - Specialty
• EPS (TTM): 0.47
• Shares Outstanding: 128,776,030
• 10 Day Avg. Volume: 1,746,546
• 30 Day Avg. Volume: 1,919,324
• PEG Ratio: 2.22
• Price to Book (P/B): 12.35
• Price to Sales (P/S): 3.08
• P/FCF Ratio: 16.56
• Enterprise Value/Market Cap: 1.56
• Enterprise Value/Revenue: 7.66
• Enterprise Value/Gross Profit: 8.99
• Enterprise Value/Ebitda: 26.64
• 1Y Price Target: $66.07
• Price Target Upside: 16.22% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 16
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 68 Neutral
• Price Target: $64.00 ▲(12.58% Upside)

Ryan Specialty Group's overall score is driven by strong financial performance and positive earnings call insights, highlighting robust revenue growth and strategic investments. However, high valuation metrics and financial leverage pose risks. Technical indicators show positive momentum, but valuation concerns weigh on the overall score.

Positive Factors

Revenue Growth

Strong revenue growth, driven by both organic expansion and strategic acquisitions, indicates robust market demand and effective business strategies, supporting long-term growth prospects.

Strategic Investments

Investments in talent and technology enhance competitive positioning and innovation capacity, crucial for sustaining growth and adapting to market changes.

M&A Activity

Active M&A strategy strengthens market position and diversifies revenue streams, providing resilience against market fluctuations and enhancing growth potential.

Negative Factors

High Leverage

High leverage can constrain financial flexibility and increase vulnerability to economic downturns, potentially impacting long-term financial stability.

Margin Pressure

Margin pressures from strategic investments may limit short-term profitability, challenging the company's ability to maintain high operational efficiency.

Interest Expense Concerns

Flat interest expenses amid a declining rate environment could strain profitability, affecting cash flow and limiting investment capacity.

Ryan Specialty Group Business Overview & Revenue Model

Company Description

Ryan Specialty Group (RYAN) is a leading international specialty insurance and reinsurance brokerage firm headquartered in Chicago, Illinois. The company operates through various segments, including wholesale brokerage, managing general underwriting, and insurance services, providing tailored insurance solutions across multiple sectors such as healthcare, construction, and technology. RYAN's core services involve the placement of complex insurance risks and the development of innovative insurance products to meet the unique needs of its clients.

How the Company Makes Money

Ryan Specialty Group generates revenue primarily through commissions and fees earned from its brokerage services, which involve placing insurance coverage for clients with various carriers. The company also earns income from its managing general underwriting operations, where it underwrites specific insurance products and retains a portion of the premiums. Key revenue streams include transaction-based commissions from insurance placements, ongoing fees from clients for advisory services, and premiums collected from the insurance products it underwrites. Significant partnerships with various insurance carriers enhance RYAN's ability to offer a diverse range of products, while its reputation in the specialty market allows it to attract a broad client base, contributing to its overall earnings.

Ryan Specialty Group Financial Statement Overview

Summary

Ryan Specialty Group shows strong revenue growth and operational efficiency, but faces challenges with high leverage and low net profit margins. Cash flow management is improving, but the company should focus on enhancing profitability and reducing financial risk to strengthen its financial position.

Income Statement

Ryan Specialty Group shows strong revenue growth with a TTM increase of 5.33% and consistent annual growth. Gross profit margins are high, indicating effective cost management. However, net profit margins are relatively low, suggesting room for improvement in profitability. EBIT and EBITDA margins are healthy, reflecting operational efficiency.

Balance Sheet

The company has a high debt-to-equity ratio, which poses a financial risk, but it has been relatively stable over the years. The return on equity is moderate, indicating decent profitability relative to shareholder investment. The equity ratio is low, suggesting a high reliance on debt financing.

Cash Flow

Free cash flow growth is positive, showing improvement in cash generation. The operating cash flow to net income ratio is low, indicating potential issues in converting income into cash. However, the free cash flow to net income ratio is strong, suggesting good cash flow management relative to earnings.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.96B	2.52B	2.08B	1.73B	1.43B	1.02B
Gross Profit	2.52B	2.52B	2.08B	1.73B	1.43B	1.02B
EBITDA	851.89M	598.63M	473.27M	393.31M	253.60M	194.21M
Net Income	69.17M	94.67M	61.04M	61.05M	65.87M	68.10M
Balance Sheet
Total Assets	9.85B	9.65B	7.25B	6.38B	5.46B	4.53B
Cash, Cash Equivalents and Short-Term Investments	153.49M	540.20M	838.79M	992.72M	386.96M	312.65M
Total Debt	3.58B	3.46B	2.16B	2.16B	1.68B	1.69B
Total Liabilities	8.62B	8.55B	6.27B	5.57B	4.86B	4.21B
Stockholders Equity	630.47M	627.66M	559.75M	478.40M	343.77M	318.93M
Cash Flow
Free Cash Flow	572.09M	467.87M	447.43M	320.47M	263.71M	122.89M
Operating Cash Flow	640.06M	514.87M	477.20M	335.51M	273.49M	135.39M
Investing Cash Flow	-1.18B	-1.76B	-476.23M	-22.42M	-457.94M	-768.51M
Financing Cash Flow	546.83M	1.17B	-12.61M	314.76M	429.28M	1.13B

Ryan Specialty Group Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 56.85
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RYAN, the sentiment is Negative. The current price of 56.85 is below the 20-day moving average (MA) of 57.10, above the 50-day MA of 55.50, and below the 200-day MA of 62.79, indicating a neutral trend. The MACD of 0.66 indicates Positive momentum. The RSI at 52.12 is Neutral, neither overbought nor oversold. The STOCH value of 50.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RYAN.

Ryan Specialty Group Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MTG	78 Outperform	$6.35B	9.12	14.40%	1.98%	2.20%	9.90%
FAF	77 Outperform	$6.63B	13.98	9.28%	3.47%	25.99%	426.44%
FNF	74 Outperform	$15.87B	13.62	14.22%	3.51%	3.91%	55.78%
AIZ	73 Outperform	$11.09B	13.47	15.41%	1.48%	6.91%	17.60%
ESNT	73 Outperform	$6.10B	9.02	12.35%	2.00%	2.78%	-0.50%
RYAN	68 Neutral	$14.52B	431.95	11.16%	0.84%	22.77%	-34.97%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%

Ryan Specialty Group Corporate Events

Ryan Specialty Group’s Earnings Call: Growth Amid Challenges

Ryan Specialty Group Holdings, Inc. Class A recently held its earnings call, revealing a strong performance driven by significant revenue growth, successful mergers and acquisitions (M&A), and strategic investments in talent and technology. Despite these positive developments, the company faces challenges with margin pressures, property pricing headwinds, and interest expenses, leading to a balanced outlook.

Ryan Specialty Group Reports Strong Q3 2025 Results

Ryan Specialty Group Holdings, Inc. operates as a prominent international specialty insurance firm, providing innovative solutions in the insurance sector through its roles as a wholesale broker and managing underwriter. The company focuses on delivering specialty products and services to insurance brokers, agents, and carriers.

Ryan Specialty Group Reports Strong Q3 2025 Results

Ryan Specialty Holdings reported strong financial results for the third quarter ended September 30, 2025, with a 24.8% year-over-year increase in total revenue to $754.6 million. The company achieved significant growth in net income, adjusted EBITDAC, and adjusted diluted earnings per share, driven by organic growth and strategic investments in talent and technology, positioning itself as a leader in the specialty lines industry.

The most recent analyst rating on (RYAN) stock is a Buy with a $97.00 price target. To see the full list of analyst forecasts on Ryan Specialty Group stock, see the RYAN Stock Forecast page.

Ryan Specialty Group Appoints New Co-Presidents

On October 8, 2025, Ryan Specialty Holdings, Inc. announced the appointment of Stephen P. Keogh and Brendan M. Mulshine as Co-Presidents, succeeding Jeremiah Bickham who transitioned to a strategic advisor role. This leadership change is expected to leverage the extensive industry experience of both executives to drive the company’s continued growth and success, reflecting the firm’s commitment to sustainable and profitable expansion.

The most recent analyst rating on (RYAN) stock is a Buy with a $70.00 price target. To see the full list of analyst forecasts on Ryan Specialty Group stock, see the RYAN Stock Forecast page.

Ryan Specialty Group Appoints Michael Bungert to Board

On September 3, 2025, Ryan Specialty Holdings, Inc. appointed Michael G. Bungert, a veteran in the (re)insurance industry, to its Board of Directors and its Compensation and Governance Committee. Mr. Bungert, who has extensive experience in the insurance sector, is expected to bring strategic insights to the company. His appointment is seen as a move to strengthen Ryan Specialty’s position as a leader in the specialty insurance market, with Mr. Bungert’s experience anticipated to contribute to the firm’s innovative solutions and forward momentum.

The most recent analyst rating on (RYAN) stock is a Buy with a $68.00 price target. To see the full list of analyst forecasts on Ryan Specialty Group stock, see the RYAN Stock Forecast page.